FDC
Back to Balance Sheet
|
FDC Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹108 Cr | ₹74 Cr | ₹60 Cr | ₹56 Cr | ₹38 Cr |
What is the latest Contingent Liabilities ratio of FDC ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹108 Cr |
| Mar2024 | ₹74 Cr |
| Mar2023 | ₹60 Cr |
| Mar2022 | ₹56 Cr |
| Mar2021 | ₹38 Cr |
How is Contingent Liabilities of FDC Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹108 Cr | 44.57 | |
| Mar2024 | ₹74 Cr | 24.95 | |
| Mar2023 | ₹60 Cr | 5.77 | |
| Mar2022 | ₹56 Cr | 48.30 | |
| Mar2021 | ₹38 Cr | - | |
Compare Contingent Liabilities of peers of FDC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FDC | ₹7,500.2 Cr | 6.6% | 4.2% | -12.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹405,452.0 Cr | -0.3% | 6% | -10.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,089.0 Cr | 3.9% | 18.6% | 14.5% | Stock Analytics | |
| CIPLA | ₹121,299.0 Cr | -5.2% | NA | 2.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹120,456.0 Cr | -1% | -1.2% | 8.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,965.9 Cr | -6.8% | -2.1% | -8.4% | Stock Analytics | |
FDC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FDC | 6.6% |
4.2% |
-12.3% |
| SENSEX | -0.3% |
4.5% |
5.7% |
You may also like the below Video Courses